The Importance of Collaborative Engagement in Regulatory Discussions
OPINION The upcoming 15th Industry Standing Group meeting presents a pivotal opportunity for stakeholders in the pharmaceutical sector to engage in meaningful dialogue with regulatory authorities. Such gatherings are essential…
The Importance of Patient and Healthcare Professional Engagement in Regulatory Discussions
OPINION The upcoming meeting organized by the European Medicines Agency (EMA) highlights a crucial intersection of patient advocacy and regulatory oversight. Engaging both patients and healthcare professionals is not merely…
The Future of Data in Medicine: A Critical Perspective
OPINION The upcoming EMA/HMA annual data forum represents a pivotal moment for the intersection of regulatory oversight and data management in the pharmaceutical sector. As the landscape of medicine becomes…
The Importance of Transparent Communication in Regulatory Events
OPINION The upcoming Quarterly System Demo hosted by the European Medicines Agency (EMA) serves as a crucial platform for stakeholders in the pharmaceutical and healthcare sectors. In an era where…
The Importance of Non-Clinical Data in Regulatory Decision-Making — 2025-12-11 22:15
OPINION The upcoming EMA workshop on non-clinical data for regulatory decision-making highlights a crucial, yet often overlooked, aspect of medical countermeasures. In an age where clinical trials tend to dominate…
The Future of Drug Approval: Insights from the CHMP Meeting
OPINION The Committee for Medicinal Products for Human Use (CHMP) is set to convene in December 2025, a pivotal moment for the European Medicines Agency and the future of drug…
The Importance of Industry Collaboration in Pharmaceutical Research
OPINION The upcoming 15th industry stakeholder platform on research and development support at the European Medicines Agency marks a pivotal moment for the pharmaceutical industry. In an era where collaboration…
The Growing Need for Coordinated Responses to Medicine Shortages
OPINION The convening of the Medicine Shortages Single Point of Contact (SPOC) Working Party highlights a crucial shift in how the healthcare industry is addressing the pervasive issue of medicine…
The Importance of Pediatric Research in Drug Development
OPINION The upcoming 2025 annual meeting of the European network of paediatric research at the EMA represents a critical juncture for the future of pediatric medicine. In an era where…
The Importance of Paediatric Research in Modern Medicine
OPINION The upcoming annual open meeting of the European Network of Paediatric Research at EMA (Enpr-EMA) signifies a crucial opportunity for stakeholders in the paediatric field to converge and collaborate…